According to a recent LinkedIn post from Mural Health, the company is highlighting its presence at the upcoming OCT East Coast conference and promoting discussions around improving the clinical trial patient experience. The post points to Mural Health’s Mural Link offering, which is presented as a solution for managing the full patient journey, including payments, travel, and participant support.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The emphasis on patient-centric trial operations suggests that Mural Health is positioning its technology in a niche focused on retention and engagement, key pain points for sponsors and CROs seeking to reduce trial delays and costs. Increased visibility at a specialized industry event like OCT East Coast may help the company deepen relationships with clinical trial decision-makers, potentially supporting future commercial traction and strengthening its competitive position in the decentralized and patient-support platforms segment.